Correlation Between Apogee Therapeutics, and Valens

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Valens at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Valens into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Valens, you can compare the effects of market volatilities on Apogee Therapeutics, and Valens and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Valens. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Valens.

Diversification Opportunities for Apogee Therapeutics, and Valens

0.06

Correlation Coefficient

Apogee Therapeutics,  Valens

Significant diversification

The 3 months correlation between Apogee and Valens is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Valens in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valens and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Valens. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valens has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Valens go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Valens

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 1.31 times more return on investment than Valens. However, Apogee Therapeutics, is 1.31 times more volatile than Valens. It trades about 0.08 of its potential returns per unit of risk. Valens is currently generating about -0.03 per unit of risk. If you would invest  1,700  in Apogee Therapeutics, Common on September 24, 2024 and sell it today you would earn a total of  3,027  from holding Apogee Therapeutics, Common or generate 178.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	73.69%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Valens

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Valens

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Valens has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Apogee Therapeutics, and Valens

The main advantage of trading using opposite Apogee Therapeutics, and Valens positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Valens can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valens will offset losses from the drop in Valens' long position.

The idea behind Apogee Therapeutics, Common and Valens pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..